Therapeutic Potential of a Biodynamic Supplement on Skin Pressure Ulcers: A Randomized Clinical Study

• Published in: Biomedicines Vol. 12; no. 8; p. 1918
• Main Authors: Ferorelli, Pasquale, Doepp, Manfred, Lenzi, Stefano, Rovelli, Roberto, Gisonna, Gennaro, Maierà, Giuseppe, Antonelli, Francesco, Radaelli, Massimo, Shevchenko, Anna, Feriotto, Giordana, Mischiati, Carlo, Borromeo, Ilaria, Beninati, Simone
• Format: Journal Article
• Language: English
• Published: Switzerland MDPI AG 01.08.2024; MDPI
• Subjects: Bedsores; biodynamic therapy; Carbohydrates; Care and treatment; Consent; Dietary supplements; Enzymes; Lactase; Leg ulcers; Malnutrition; Medical nutrition therapy; Medical personnel; Medical research; Metabolism; Nutrition; nutritional supplement; Patients; Photographic equipment & supplies; Pressure ulcers; Skin; Skin diseases; Testing; Ulcers; Vascular diseases; Vitamins; Wound healing; Italy; nutritional supplement; pressure ulcers; biodynamic therapy
• ISSN: 2227-9059; 2227-9059
• DOI: 10.3390/biomedicines12081918

Pressure ulcers (PUs) are a debilitating and often painful condition. They are localized lesions on the skin and/or underlying tissues and are common in the elderly, people with mobility difficulties, diabetics, and vascular disease or malnutrition, as well as in those requiring intensive or palliative care. The prevention and treatment of PUs involve strategies to optimize hydration, circulation, and nutrition. Nutrition plays a key role in pressure ulcer care because wounds require macronutrients and micronutrients to heal. Reports relating to the effectiveness of "Complementary Enzyme Therapy" also in the vulnological field led us to this study, the aim of which was to test the activity of a biodynamic food supplement (Citozym ) rich in carbohydrates, vitamins, and amylase and lactase and characterized by marked antioxidant activity. Citozym administered topically and/or systemically, and in particular in both administrations, in patients suffering from Pus, has shown a marked reduction in bedsores and, in many cases, complete healing. Furthermore, it was possible to observe a lower incidence of side effects compared to conventional therapies. The results obtained, confirmed by various tests and recognized by the scientific community, allow us to conclude that treatment with Citozym could represent a new and effective strategy for the treatment of PUs.